Truist Securities Rates Progyny (PGNY) buy, $33 Price Target
Truist Securities maintains its buy rating and sets a $33 price target for Progyny, Inc, a 22.72% upside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
Truist Securities rated Progyny, Inc. ($PGNY) "buy" with a $33 price target on June 22, 2026.
Since the rating, $PGNY is up 9.8% after 1 week, up 19.3% after 1 month and up 2.2% to date (from the $26.28 close on Jun 22, 2026).
PGNY
Progyny, Inc.
Key Points
- Truist Securities reiterated its buy rating on Progyny, Inc. (PGNY) with a $33 price target on June 22, 2026.
- Truist Securities's $33 price target implies 22.72% upside from Progyny, Inc.'s ($PGNY) current $26.89 share price.
- Progyny shares traded around $26.08 on Tuesday, with a market cap of approximately $2.06 billion and a P/E ratio of 34.1.
- Insider transactions included CFO Mark Livingston selling 2,517 shares on June 4, 2026, under a planned sale.
Get $PGNY trade alerts by text
We text you when insiders, Congress or big funds trade $PGNY. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Progyny, Inc. alert may contain errors. Disclosures
Truist Securities has reiterated its buy rating on Progyny, Inc. (NasdaqGS: PGNY), maintaining a price target of $33. This update came from analyst Jailendra Singh on June 22, 2026. Shares of Progyny traded at around $26.08 on that day.
Truist Securities vs. the S&P 500
Hypothetical returns from Truist Securities's disclosed trades, not real profit or advice. How we model this.
Progyny, Inc. Stock Down 0.9%
Shares of NasdaqGS:PGNY traded near $26.08 on Tuesday. Progyny, Inc. has a market cap of about $2.06 billion, with a P/E ratio of 34.1 and a forward P/E of 11.9. The stock has seen a 52-week low of $16.10 and a high of $28.75. Its 50-day moving average is $22.15, while the 200-day moving average is $22.08. The company maintains a current ratio of 2.13 and a quick ratio of 2.07, with a debt-to-equity ratio of 6.21.
$PGNY price target
Progyny, Inc. daily closes and this analyst's $33 target. Not advice.
Recent Earnings
Progyny reported revenue of approximately $1.29 billion, reflecting a growth rate of 1.4%. The company's earnings per share (EPS) stood at $0.77. Progyny's net margin was 5.2%, with a return on equity (ROE) of 14.9%. The next earnings report is scheduled for August 6, 2026.
Insider Buying and Selling at Progyny, Inc.
Recent insider transactions included Chief Financial Officer Mark Livingston selling 2,517 shares at an average price of $25.50 on June 4, 2026, as part of a planned sale. Additionally, Executive Vice President and General Counsel Allison Swartz sold 599 shares at $25.08 on the same day, also under a planned sale.
Analysts Set New Price Targets
On June 22, 2026, Truist Securities maintained its buy rating on Progyny, Inc. with a price target of $33. Earlier, on June 2, 2026, B of A Securities also maintained a buy rating with a $31 target. Canaccord Genuity upgraded the stock to a buy with a $30 target on May 19, 2026. Overall, the stock has a consensus rating of "strong buy" with an average price target of $29.73 across 11 analyst opinions.
About Progyny, Inc.
Progyny, Inc. is a healthcare company based in New York, NY, that provides fertility and family-building benefits solutions. The company offers a comprehensive benefits package including fertility treatments, pharmacy benefits, and various support services. Progyny is led by CEO Peter Anevski and employs around 835 people. It was incorporated in 2008 and operates primarily in the United States.
Bottom Line
Truist Securities' reaffirmation of its buy rating on Progyny, Inc. highlights the firm's positive outlook on the company. Investors often track these ratings to gauge market sentiment, though it's important to remember that these analyst updates are forward-looking opinions and not guarantees. Progyny's financial health and strategic positioning in the healthcare sector make it a company to watch.
Related Filing Alerts
Source: Truist Securities's rating change on $PGNY (Jun 22, 2026). Written by software, not financial advice. How we make alerts